Achilles Therapeutics Ownership | Who Owns Achilles Therapeutics?

Achilles Therapeutics Ownership Summary

Achilles Therapeutics is owned by 55.08% institutional investors, 6.52% insiders, and 38.40% retail investors. Syncona portfolio is the largest institutional shareholder, holding 27.52% of ACHL shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.05% of its assets in Achilles Therapeutics shares.

ACHL Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Achilles Therapeutics	55.08%	6.52%	38.40%
Sector	Healthcare Stocks	46.80%	8.14%	45.06%
Industry	Biotech Stocks	44.70%	7.99%	47.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Syncona portfolio	11.09M	27.52%	$9.04M
Fcpm iii services b.v.	2.39M	5.93%	$1.95M
Redmile group	1.61M	3.99%	$1.31M
Vestal point capital, lp	1.50M	3.72%	$1.22M
Ikarian capital	1.44M	3.58%	$1.18M
Artal group	755.38K	1.88%	$615.63K
Renaissance	682.73K	1.69%	$556.43K
Bml capital management	625.17K	1.55%	$509.52K
Boothbay fund management	420.48K	1.04%	$342.69K
Acadian asset management	250.82K	0.62%	$203.00K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Syncona portfolio	11.09M	10.52%	$9.04M
Bml capital management	625.17K	0.36%	$509.52K
Fcpm iii services b.v.	2.39M	0.29%	$1.95M
Ikarian capital	1.44M	0.20%	$1.18M
Vestal point capital, lp	1.50M	0.09%	$1.22M
Redmile group	1.61M	0.08%	$1.31M
Artal group	755.38K	0.02%	$615.63K
Boothbay fund management	420.48K	0.01%	$342.69K
Brave asset management	10.00K	0.00%	$8.15K
Virtu financial	22.81K	0.00%	$19.00K

Top Buyers

Holder	Shares	% Assets	Change
Bml capital management	625.17K	0.36%	625.17K
Ubs group	65.70K	-	65.70K
Baader bank aktiengesellschaft	12.37K	0.00%	12.37K
Two sigma investments, lp	21.48K	-	9.68K
Two sigma advisers, lp	23.50K	-	5.60K

Top Sellers

Holder	Shares	% Assets	Change
Stempoint capital lp	-	-	-1.39M
Baker bros. advisors lp	-	-	-1.11M
Renaissance	682.73K	0.00%	-323.02K
Forefront analytics	-	-	-95.44K
Xtx topco	-	-	-51.66K

New Positions

Holder	Shares	% Assets	Change	Value
Bml capital management	625.17K	0.36%	625.17K	$509.52K
Ubs group	65.70K	-	65.70K	$53.55K
Baader bank aktiengesellschaft	12.37K	0.00%	12.37K	$8.21K

Sold Out

Holder	Change
Qube research	-73.00
Ica group wealth management	-400.00
Bank of america corp /de/	-1.09K
Global retirement partners	-2.00K
Resources investment advisors, llc.	-10.50K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	26	-16.13%	22,188,649	-5.62%	55	1.61%	8	-55.56%	6	-25.00%
Mar 31, 2024	31	63.16%	23,510,455	7.93%	58	1.98%	18	125.00%	8	100.00%
Dec 31, 2023	19	11.76%	21,782,170	10.61%	54	2.23%	8	33.33%	4	-
Sep 30, 2023	17	6.25%	19,692,035	-0.48%	49	1.99%	6	50.00%	4	-33.33%
Jun 30, 2023	16	-	19,786,405	-2.22%	49	1.92%	4	-33.33%	6	200.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Nasdaq Composite Index	21.59K	0.05%	-
Blackstone Alternative Multi-Strategy I	100.00	0.00%	-

ACHL Ownership FAQ

Who Owns Achilles Therapeutics?

Achilles Therapeutics shareholders are primarily institutional investors at 55.08%, followed by 6.52% insiders and 38.40% retail investors. The average institutional ownership in Achilles Therapeutics's industry, Biotech Stocks , is 44.70%, which Achilles Therapeutics exceeds.

Who owns the most shares of Achilles Therapeutics?

Achilles Therapeutics’s largest shareholders are Syncona portfolio (11.09M shares, 27.52%), Fcpm iii services b.v. (2.39M shares, 5.93%), and Redmile group (1.61M shares, 3.99%). Together, they hold 37.45% of Achilles Therapeutics’s total shares outstanding.

Does Blackrock own Achilles Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Achilles Therapeutics.

Who is Achilles Therapeutics’s biggest shareholder by percentage of total assets invested?

Syncona portfolio is Achilles Therapeutics’s biggest shareholder by percentage of total assets invested, with 10.52% of its assets in 11.09M Achilles Therapeutics shares, valued at 9.04M$.

Who is the top mutual fund holder of Achilles Therapeutics shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Achilles Therapeutics shares, with 0.05% of its total shares outstanding invested in 21.59K Achilles Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools